CX 2023 Full programme
Day 1 Afternoon: Peripheral Arterial & Chronic Limb Threatening Ischaemia (CLTI) - Tuesday, 25th April
Venue: Kensington 1 / Livestream 1
Time: 13:30 - 18:00
14:50 - 14:55
Update on the MOTIV trial: Sirolimus-eluting bioresorbable scaffold for BTK artery disease - Tuesday, 25th April
Speaker: | Michel Bosiers, Bern, Switzerland |